{"id":542,"date":"2018-09-06T09:00:00","date_gmt":"2018-09-06T09:00:00","guid":{"rendered":"https:\/\/isosolution-v2.staging.xiyx.ai\/news\/single-low-dose-injection-of-evans-blue-modified-psma-617-radioligand-therapy-eliminates-prostate-specific-membrane-antigen-positive-tumors\/"},"modified":"2018-09-06T09:00:00","modified_gmt":"2018-09-06T09:00:00","slug":"single-low-dose-injection-of-evans-blue-modified-psma-617-radioligand-therapy-eliminates-prostate-specific-membrane-antigen-positive-tumors","status":"publish","type":"iso_news","link":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/news\/single-low-dose-injection-of-evans-blue-modified-psma-617-radioligand-therapy-eliminates-prostate-specific-membrane-antigen-positive-tumors\/","title":{"rendered":"Injection unique \u00e0 faible dose d'Evans Blue modifi\u00e9 PSMA-617 Radioligand Therapy \u00e9limine les tumeurs positives de l'antig\u00e8ne membranaire sp\u00e9cifique \u00e0 la prostate"},"content":{"rendered":"<p>Le cancer de la prostate est la tumeur maligne la plus fr\u00e9quemment diagnostiqu\u00e9e chez les hommes dans le monde. L'antig\u00e8ne membranaire sp\u00e9cifique \u00e0 la prostate (PSMA) est une mol\u00e9cule de surface express\u00e9ment exprim\u00e9e par les tumeurs de la prostate et il a \u00e9t\u00e9 d\u00e9montr\u00e9 qu'elle est une cible valide pour la radionucl\u00e9oth\u00e9rapie interne dans un contexte pr\u00e9clinique et clinique. L'agent radioth\u00e9rapeutique le plus courant est la petite mol\u00e9cule 177Lu-PSMA-617,  <a href=\"https:\/\/isosolutions.com\/single-low-dose-injection-of-evans-blue-modified-psma-617-radioligand-therapy-eliminates-prostate-specific-membrane-antigen-positive-tumors\/\"><span aria-label=\"Continuer la lecture Injection unique \u00e0 faible dose d&#039;Evans Blue modifi\u00e9 PSMA-617 Radioligand Therapy \u00e9limine les tumeurs positives de l&#039;antig\u00e8ne membrane sp\u00e9cifiques \u00e0 la prostate\">(plus...)<\/span><\/a><\/p>\n<\/p><\/div>\n<p>\u00c9tiquettes : <a href=\"https:\/\/isosolutions.com\/news-tag\/global\/\" rel=\"tag\">Mondial<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/isosolutions\/\" rel=\"tag\">isoSolutions<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/lu-177\/\" rel=\"tag\">Lu-177<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/radiochemicals\/\" rel=\"tag\">Produits radiochimiques<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/research\/\" rel=\"tag\">Recherche<\/a><\/p>\n<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>Prostate cancer is the most frequently diagnosed malignant tumor in men worldwide. Prostate-specific membrane antigen (PSMA) is a surface molecule specifically expressed by prostate tumors and has\u2026<\/p>","protected":false},"featured_media":568,"template":"","iso_news_section":[43],"class_list":["post-542","iso_news","type-iso_news","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news\/542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news"}],"about":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/types\/iso_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/media\/568"}],"wp:attachment":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/media?parent=542"}],"wp:term":[{"taxonomy":"iso_news_section","embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news_section?post=542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}